生物信息分析和实验验证表明,在病的发病过程中,存在STAT2介导的血管性反应
Bancheng Chen1, Chenchen Wu1, Yan Liao1
1Department of Dermatology, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong Province, China.
Archives of dermatological research
|February 13, 2025
概括
这项研究基于血管新生基因确定了粉红疹中独特的分子模式. 在特定的粉红亚型中,STAT2蛋白升高,并促进血管形成,这表明它是潜在的治疗点.
科学领域:
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 红是一种慢性炎症性皮肤疾病.
- 血管异常与粉红疹病变的发生有关.
- 在粉红病变中存在明显的血管性分子模式.
研究的目的:
- 根据血管性基因表达来表征粉红病亚型.
- 为了研究免疫细胞透与血管生成模式的关系.
- 探索STAT2在疹血管生成中的作用.
主要方法:
- 对GSE65914基因表达数据集的分析.
- 在粉红亚型中识别免疫特征.
- 在疹患者和小鼠模型中验证STAT2表达.
- 在人静脉内皮细胞 (HUVEC) 的体外实验.
主要成果:
- 粉红斑样本被分类为不同的血管性分子模式.
- 独特的免疫特征与VEGFA高MMP9低和VEGFA低MMP9高亚型相关.
- 在VEGFA高MMP9低组中,STAT2蛋白水平较高,在疹患者和小鼠模型中得到证实.
- STAT2倒置抑制了HUVEC管的形成,表明它在血管生成中的作用.
结论:
- 粉红病可以根据不同的血管性分子概况进行亚型.
- STAT2在调节粉红病中的血管性反应方面发挥着至关重要的作用.
- STAT2代表了治疗的潜在治疗标.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Mechanism of Angiogenesis
5.2K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.2K
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K


